Global Biologics Contract Manufacturing Market By Product Type (Monoclonal Antibodies, Vaccines, Gene Therapy, Cell Therapy and Others), By Indication (Oncology, Autoimmune Diseases, Cardiovascular Diseases, Infectious Diseases and Other), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Table of Content

• 1. Research Methodology and Data Source
  • 1.1. Methodology/Research Approach
  • 1.2. Market Size Estimation
  • 1.3. Market Breakdown and Data Triangulation
  • 1.4. Data Sources
  • 1.5. Secondary Sources
  • 1.6. Primary Sources
• 2. Executive Summary
  • 2.1. Taxonomy
  • 2.2. Global Market Outlook
  • 2.3. Key Facts and Figures
  • 2.4. Major Players in Biologics Contract Manufacturing Market
• 3. Global Market Overview
  • 3.1. Industry Overview
  • 3.2. Segmental Overview
  • 3.3. Regional Overview
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
    • 3.4.4. Trends
  • 3.5. Regulatory Framework
  • 3.6. Opportunity Map Analysis
  • 3.7. Opportunity Orbits
  • 3.8. Market Investment Feasibility Index
  • 3.9. PESTLE Analysis
  • 3.10. PORTER’S Five Force Analysis
  • 3.11. Drivers & Restraints Impact Analysis
  • 3.12. Patient Journey Mapping
  • 3.13. Technological Landscape
  • 3.14. Product Life Cycle Analysis
  • 3.15. Value Chain Analysis
    • 3.15.1. List of Raw Material Suppliers
    • 3.15.2. List of Biologics Contract Manufacturing Manufacturers
    • 3.15.3. List of Dealer/Distributors
    • 3.15.4. List of Potential Customers
  • 3.16. Cost Structure Analysis
  • 3.17. Regional Market Share and BPS Analysis
• 4. Macro-economic Factors
• 5. Impact of Current Geopolitical Scenario
• 6. Global Biologics Contract Manufacturing Market Analysis and Forecast, By Product Type
  • 6.1. Key Findings
  • 6.2. Global Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 6.2.1. Monoclonal Antibodies
    • 6.2.2. Vaccines
    • 6.2.3. Gene Therapy
    • 6.2.4. Cell Therapy
    • 6.2.5. Others
  • 6.3. Global Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
• 7. Global Biologics Contract Manufacturing Market Analysis and Forecast, By Indication
  • 7.1. Key Findings
  • 7.2. Global Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 7.2.1. Oncology
    • 7.2.2. Autoimmune Diseases
    • 7.2.3. Cardiovascular Diseases
    • 7.2.4. Infectious Diseases
    • 7.2.5. Other
• 7.3. Global Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
• 8. Global Biologics Contract Manufacturing Market Analysis and Forecast, By Region
  • 8.1. Key Findings
  • 8.2. Global Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Region, 2020-2035
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Middle East & Africa
    • 8.2.5. Latin America
  • 8.3. Global Biologics Contract Manufacturing Market Attractiveness Analysis, By Region
• 9. North America Biologics Contract Manufacturing Market Analysis and Forecast, 2020-2035
  • 9.1. Key Findings
  • 9.2. North America Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
  • 9.3. North America Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
  • 9.4. North America Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
  • 9.5. North America Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
  • 9.6. North America Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Country, 2020-2035
  • 9.7. North America Biologics Contract Manufacturing Market Attractiveness Analysis, By Country
    • 9.7.1. The US Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 9.7.2. The US Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 9.7.3. Canada Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 9.7.4. Canada Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
• 10. Europe Biologics Contract Manufacturing Market Analysis and Forecast, 2020-2035
  • 10.1. Key Findings
  • 10.2. Europe Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
  • 10.3. Europe Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
  • 10.4. Europe Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
  • 10.5. Europe Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
  • 10.6. Europe Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Country, 2020-2035
  • 10.7. Europe Biologics Contract Manufacturing Market Attractiveness Analysis, By Country
    • 10.7.1. Germany Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 10.7.2. Germany Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 10.7.3. The U.K. Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 10.7.4. The U.K. Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 10.7.5. France Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 10.7.6. France Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 10.7.7. Spain Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 10.7.8. Spain Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 10.7.9. Italy Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 10.7.10. Italy Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 10.7.11. Russia & CIS Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 10.7.12. Russia & CIS Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 10.7.13. Rest of Europe Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 10.7.14. Rest of Europe Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
• 11. Asia Pacific Biologics Contract Manufacturing Market Analysis and Forecast, 2020-2035
  • 11.1. Key Findings
  • 11.2. Asia Pacific Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
  • 11.3. Asia Pacific Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
  • 11.4. Asia Pacific Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
  • 11.5. Asia Pacific Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
  • 11.6. Asia Pacific Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Country, 2020-2035
  • 11.7. Asia Pacific Biologics Contract Manufacturing Market Attractiveness Analysis, By Country
    • 11.7.1. China Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 11.7.2. China Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 11.7.3. India Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 11.7.4. India Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 11.7.5. Japan Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 11.7.6. Japan Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 11.7.7. South Korea Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 11.7.8. South Korea Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 11.7.9. ASEAN Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 11.7.10. ASEAN Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 11.7.11. Australia & New Zealand Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 11.7.12. Australia & New Zealand Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 11.7.13. Rest of Asia Pacific Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 11.7.14. Rest of Asia Pacific Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
• 12. Middle East & Africa Biologics Contract Manufacturing Market Analysis and Forecast, 2020-2035
  • 12.1. Key Findings
  • 12.2. Middle East & Africa Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
  • 12.3. Middle East & Africa Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
  • 12.4. Middle East & Africa Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
  • 12.5. Middle East & Africa Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
  • 12.6. Middle East & Africa Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Country, 2020-2035
  • 12.7. Middle East & Africa Biologics Contract Manufacturing Market Attractiveness Analysis, By Country
    • 12.7.1. GCC Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 12.7.2. GCC Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 12.7.3. South Africa Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 12.7.4. South Africa Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 12.7.5. Rest of Middle East & Africa Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 12.7.6. Rest of Middle East & Africa Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
• 13. Latin America Biologics Contract Manufacturing Market Analysis and Forecast, 2020-2035
  • 13.1. Key Findings
  • 13.2. Latin America Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
  • 13.3. Latin America Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
  • 13.4. Latin America Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
  • 13.5. Latin America Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
  • 13.6. Latin America Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Country, 2020-2035
  • 13.7. Latin America Biologics Contract Manufacturing Market Attractiveness Analysis, By Country
    • 13.7.1. Brazil Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 13.7.2. Brazil Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 13.7.3. Mexico Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 13.7.4. Mexico Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 13.7.5. Rest of Latin America Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 13.7.6. Rest of Latin America Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
• 14. Competitive Landscape & Company Profiles
  • 14.1. Market Competition Scenario Analysis, By Company
  • 14.2. Competitor Landscape
  • 14.3. Company Share Analysis
  • 14.4. Company Profiles
    • 14.4.1. Thermo Fisher Scientific
      • 14.4.1.1. Company Details
      • 14.4.1.2. Business Overview
      • 14.4.1.3. Product Portfolio
      • 14.4.1.4. Financial Insights
      • 14.4.1.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 14.4.1.6. SWOT Analysis
      • 14.4.1.7. Geographic Footprint
    • 14.4.2. Samsung Biologics
      • 14.4.2.1. Company Details
      • 14.4.2.2. Business Overview
      • 14.4.2.3. Product Portfolio
      • 14.4.2.4. Financial Insights
      • 14.4.2.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 14.4.2.6. SWOT Analysis
      • 14.4.2.7. Geographic Footprint
    • 14.4.3. Lonza Group
      • 14.4.3.1. Company Details
      • 14.4.3.2. Business Overview
      • 14.4.3.3. Product Portfolio
      • 14.4.3.4. Financial Insights
      • 14.4.3.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 14.4.3.6. SWOT Analysis
      • 14.4.3.7. Geographic Footprint
    • 14.4.4. Catalent
      • 14.4.4.1. Company Details
      • 14.4.4.2. Business Overview
      • 14.4.4.3. Product Portfolio
      • 14.4.4.4. Financial Insights
      • 14.4.4.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 14.4.4.6. SWOT Analysis
      • 14.4.4.7. Geographic Footprint
    • 14.4.5. Samsung Bioepis
      • 14.4.5.1. Company Details
      • 14.4.5.2. Business Overview
      • 14.4.5.3. Product Portfolio
      • 14.4.5.4. Financial Insights
      • 14.4.5.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 14.4.5.6. SWOT Analysis
      • 14.4.5.7. Geographic Footprint
    • 14.4.6. Fujifilm Diosynth Biotechnologies
      • 14.4.6.1. Company Details
      • 14.4.6.2. Business Overview
      • 14.4.6.3. Product Portfolio
      • 14.4.6.4. Financial Insights
      • 14.4.6.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 14.4.6.6. SWOT Analysis
      • 14.4.6.7. Geographic Footprint
    • 14.4.7. Wuxi Biologics
      • 14.4.7.1. Company Details
      • 14.4.7.2. Business Overview
      • 14.4.7.3. Product Portfolio
      • 14.4.7.4. Financial Insights
      • 14.4.7.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 14.4.7.6. SWOT Analysis
      • 14.4.7.7. Geographic Footprint
    • 14.4.8. BioVectra
      • 14.4.8.1. Company Details
      • 14.4.8.2. Business Overview
      • 14.4.8.3. Product Portfolio
      • 14.4.8.4. Financial Insights
      • 14.4.8.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 14.4.8.6. SWOT Analysis
      • 14.4.8.7. Geographic Footprint
    • 14.4.9. Boehringer Ingelheim BioXcellence
      • 14.4.9.1. Company Details
      • 14.4.9.2. Business Overview
      • 14.4.9.3. Product Portfolio
      • 14.4.9.4. Financial Insights
      • 14.4.9.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 14.4.9.6. SWOT Analysis
      • 14.4.9.7. Geographic Footprint
    • 14.4.10. AGC Biologics
      • 14.4.10.1. Company Details
      • 14.4.10.2. Business Overview
      • 14.4.10.3. Product Portfolio
      • 14.4.10.4. Financial Insights
      • 14.4.10.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 14.4.10.6. SWOT Analysis
      • 14.4.10.7. Geographic Footprint

List of Tables

• Table 1: Global Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 2: Global Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 3: Global Biologics Contract Manufacturing Market Value (US$ Mn), By Region, 2020-2035
• Table 4: North America Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 5: North America Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 6: North America Biologics Contract Manufacturing Market Value (US$ Mn), By Country, 2020-2035
• Table 7: The US Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 8: The US Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 9: Canada Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 10: Canada Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 11: Europe Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 12: Europe Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 13: Europe Biologics Contract Manufacturing Market Value (US$ Mn), By Country, 2020-2035
• Table 14: Germany Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 15: Germany Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 16: The U.K. Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 17: The U.K. Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 18: France Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 19: France Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 20: Spain Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 21: Spain Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 22: Italy Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 23: Italy Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 24: Russia & CIS Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 25: Russia & CIS Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 26: Rest of Europe Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 27: Rest of Europe Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 28: Asia Pacific Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 29: Asia Pacific Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 30: Asia Pacific Biologics Contract Manufacturing Market Value (US$ Mn), By Country, 2020-2035
• Table 31: China Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 32: China Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 33: India Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 34: India Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 35: Japan Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 36: Japan Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 37: South Korea Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 38: South Korea Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 39: ASEAN Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 40: ASEAN Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 41: Australia & New Zealand Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 42: Australia & New Zealand Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 43: Rest of Asia Pacific Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 44: Rest of Asia Pacific Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 45: Middle East & Africa Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 46: Middle East & Africa Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 47: Middle East & Africa Biologics Contract Manufacturing Market Value (US$ Mn), By Country, 2020-2035
• Table 48: GCC Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 49: GCC Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 50: South Africa Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 51: South Africa Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 52: Rest of Middle East & Africa Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 53: Rest of Middle East & Africa Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 54: Latin America Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 55: Latin America Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 56: Latin America Biologics Contract Manufacturing Market Value (US$ Mn), By Country, 2020-2035
• Table 57: Brazil Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 58: Brazil Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 59: Mexico Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 60: Mexico Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 61: Rest of Latin America Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 62: Rest of Latin America Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035

List of Figures

• Figure 1: Global Biologics Contract Manufacturing Market Value (US$ Mn), 2020-2035
• Figure 2: Global Biologics Contract Manufacturing Market Value Share (%) Analysis, By Product Type, 2025 & 2035
• Figure 3: Global Biologics Contract Manufacturing Market Value Share (%) Analysis, By Indication, 2025 & 2035
• Figure 4: Global Biologics Contract Manufacturing Market Value Share (%) Analysis, By Region, 2025 & 2035
• Figure 5: Global Biologics Contract Manufacturing Market Value Share (%) Analysis, By Product Type, 2020, 2025 and 2035
• Figure 6: Global Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
• Figure 7: Global Biologics Contract Manufacturing Market Value Share (%) Analysis, By Indication, 2020, 2025 and 2035
• Figure 8: Global Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
• Figure 9: Global Biologics Contract Manufacturing Market Value Share (%) Analysis, By Region, 2020, 2025 and 2035
• Figure 10: Global Biologics Contract Manufacturing Market Attractiveness Analysis, By Region
• Figure 11: North America Biologics Contract Manufacturing Market Value Share (%) Analysis, By Product Type, 2020, 2025 and 2035
• Figure 12: North America Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
• Figure 13: North America Biologics Contract Manufacturing Market Value Share (%) Analysis, By Indication, 2020, 2025 and 2035
• Figure 14: North America Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
• Figure 15: North America Biologics Contract Manufacturing Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 16: North America Biologics Contract Manufacturing Market Attractiveness Analysis, By Country
• Figure 17: Europe Biologics Contract Manufacturing Market Value Share (%) Analysis, By Product Type, 2020, 2025 and 2035
• Figure 18: Europe Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
• Figure 19: Europe Biologics Contract Manufacturing Market Value Share (%) Analysis, By Indication, 2020, 2025 and 2035
• Figure 20: Europe Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
• Figure 21: Europe Biologics Contract Manufacturing Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 22: Europe Biologics Contract Manufacturing Market Attractiveness Analysis, By Country
• Figure 23: Asia Pacific Biologics Contract Manufacturing Market Value Share (%) Analysis, By Product Type, 2020, 2025 and 2035
• Figure 24: Asia Pacific Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
• Figure 25: Asia Pacific Biologics Contract Manufacturing Market Value Share (%) Analysis, By Indication, 2020, 2025 and 2035
• Figure 26: Asia Pacific Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
• Figure 27: Asia Pacific Biologics Contract Manufacturing Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 28: Asia Pacific Biologics Contract Manufacturing Market Attractiveness Analysis, By Country
• Figure 29: Middle East & Africa Biologics Contract Manufacturing Market Value Share (%) Analysis, By Product Type, 2020, 2025 and 2035
• Figure 30: Middle East & Africa Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
• Figure 31: Middle East & Africa Biologics Contract Manufacturing Market Value Share (%) Analysis, By Indication, 2020, 2025 and 2035
• Figure 32: Middle East & Africa Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
• Figure 33: Middle East & Africa Biologics Contract Manufacturing Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 34: Middle East & Africa Biologics Contract Manufacturing Market Attractiveness Analysis, By Country
• Figure 35: Latin America Biologics Contract Manufacturing Market Value Share (%) Analysis, By Product Type, 2020, 2025 and 2035
• Figure 36: Latin America Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
• Figure 37: Latin America Biologics Contract Manufacturing Market Value Share (%) Analysis, By Indication, 2020, 2025 and 2035
• Figure 38: Latin America Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
• Figure 39: Latin America Biologics Contract Manufacturing Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 40: Latin America Biologics Contract Manufacturing Market Attractiveness Analysis, By Country